Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-639
Closed -$209K 222
2025
Q4
$209K Buy
+639
New +$203K 0.03% 214
2021
Q1
Sell
-1,264
Closed -$292K 200
2020
Q4
$292K Buy
1,264
+202
+19% +$46.6K 0.06% 137
2020
Q3
$270K Buy
1,062
+88
+9% +$21.8K 0.06% 124
2020
Q2
$230K Buy
+974
New +$222K 0.06% 131
2020
Q1
Sell
-889
Closed -$214K 126
2019
Q4
$214K Buy
+889
New +$196K 0.05% 142
2017
Q3
Sell
-1,333
Closed -$230K 95
2017
Q2
$230K Buy
+1,333
New +$217K 0.08% 117

Other funds holding AMGN

Gilbert & Cook's AMGN Position: Q1 2026 in Review

Gilbert & Cook sold out of Amgen (AMGN) in Q1 2026, closing a stake of 639 shares — an estimated $209K sold.

Gilbert & Cook first reported a position in AMGN in Q2 2017 and held it in 6 quarters. The position peaked at $292K in Q4 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Gilbert & Cook reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Gilbert & Cook sold 639 Amgen shares in Q1 2026, an estimated $209K.
  • Gilbert & Cook first reported a position in Amgen in Q2 2017 and held it in 6 quarters.
  • Gilbert & Cook's Amgen position peaked at $292K in Q4 2020.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Gilbert & Cook's 13F filing for Q1 2026, filed 5 May 2026.